Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5900112 | Diabetes Research and Clinical Practice | 2011 | 12 Pages |
Abstract
Beginning insulin analogue therapy in people with type 2 diabetes and poor blood glucose control is associated with marked improvements in diverse aspects of vascular risk factor profile without evidence of clinically significant safety or tolerability problems.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Philip Home, Nabil El Naggar, Mohammed Khamseh, Guillermo Gonzalez-Galvez, Chunduo Shen, Praful Chakkarwar, Wenying Yang,